CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
Jae-Geun Lee, Dong Gu Kang, Jung Re Yu, Youngree Kim, Jinsoek Kim, Gwanpyo Koh, Daeho Lee
Diabetes Metab J. 2011;35(2):149-158.   Published online April 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.2.149

Excel Download

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
Jae-Geun Lee, Dong Gu Kang, Jung Re Yu, Young Ree Kim, Jin Soek Kim, Gwan Pyo Koh, Dae Ho Lee
Diabetes & Metabolism Journal. 2011;35(2):149   Crossref logo
Link1 Link2 Link3
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
Diabetes mellitus. 2012;15(2):103-104   Crossref logo
Link1 Link2
Serum Adenosine deaminase activity in type 2 Diabetes Mellitus patients
M. N. Vanitha Gowda, K. C. Vasudha, S. Reshma, K. J. Sujatha
International Journal of Diabetes in Developing Countries. 2012;32(3):176-181   Crossref logo
Link1 Link2 Link3
Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?
A. Niraula, S. Thapa, S. Kunwar, M. Lamsal, N. Baral, R. Maskey
BMC Endocrine Disorders. 2018;18(1):   Crossref logo
Link1 Link2 Link3
Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
Marina Vladimirovna Shestakova
Diabetes mellitus. 2010;13(3):57-60   Crossref logo
Link1 Link2
Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus
Tomoaki Hoshino, Kentaro Yamada, Kazuhiro Masuoka, Izumi Tsuboi, Kyogo Itoh, Kyohei Nonaka, Kotaro Oizumi
Diabetes Research and Clinical Practice. 1994;25(2):97-102   Crossref logo
Link1 Link2
Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus
Tomoyuki Katsuno, Hiroki Ikeda, Mitsuyoshi Namba
Diabetes Therapy. 2016;7(2):309-320   Crossref logo
Link1 Link2 Link3 Link4
First Russian DPP-4 inhibitor Gosogliptin comparing to Vildagliptin in type 2 diabetes mellitus patients
Karina Oganesovna Galstyan, Liudmila Viktorovna Nedosugova, Nina Alexandrovna Petunina, Julia Alexandrovna Trakhtenberg, Natalia Vadimovna Vostokova, Oksana Vladimirovna Karavaeva, Tatiana Evgenievna Chasovskaya
Diabetes mellitus. 2015;19(1):89-96   Crossref logo
Link1 Link2
Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
T ZERILLI, E PYON
Clinical Therapeutics. 2007;29(12):2614-2634   Crossref logo
Link1 Link2
Effect of Some Thiol Reagents on Erythrocyte Adenosine Deaminase (ADA) Activity
R. M. (a) Corbo, R. (b) Scacchi, E. (b) Mantuano
Enzyme. 1988;39(1):50-53   Crossref logo
Link1